IHMC
- William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.